Silence Therapeutics plc
SLN365
HoFH
Date
TBD
Phase 1 readout · Date TBD estimated
What's at stake
Phase 1 trial results for SLN365 in HoFH are due Date TBD. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 8-K
verified 15h ago
“Preclinical data Preclinical data SLN365 HoFH Zerlasiran”